TIDMCVSG

RNS Number : 4752Z

CVS Group plc

14 March 2017

14 March 2017

CVS Group plc

("CVS" or the "Company")

Exercise of Options and Total Voting Rights

CVS, one of the UK's leading provider of integrated veterinary services for small and large animals, announces that 24,859 ordinary shares of 0.2 pence each ("Ordinary Shares") (the "SAYE Shares") were issued on 6 March 2017 as a result of the exercise of employee share options, in connection with the Company's December 2013 - December 2016 Save As You Earn Scheme.

The SAYE Shares rank pari passu with all existing Ordinary Shares. The issue of the SAYE Shares has been satisfied via the Company's block listing which was announced on 19 December 2016 (the "Block Listing").

The Company also announces that 965 ordinary shares of 0.2 pence each (the "New Shares") were issued on 14 March 2017 as a result of the exercise of employee share options by a former employee, in connection with the Company's December 2014 - December 2017 and December 2015 - December 2018 Save As You Earn Schemes. Application has been made for the New Shares, which rank pari passu in all respects with the Company's existing Ordinary Shares, to be admitted to trading on AIM which is expected to occur on or around 20 March 2017.

The former employee also exercised 669 employee share options in relation to the Company's December 2013 - December 2016 Save As You Earn Scheme. The issue of these SAYE Shares has been satisfied via the Block Listing and is included in the issue of 24,859 new Ordinary Shares as described above.

Following issue of the New Shares and the SAYE Shares, the Company's total issued share capital will consist of 63,877,906 Ordinary Shares with one voting right per share. The Company does not hold any Ordinary Shares in Treasury. Therefore, following the issue of the New Shares, the total number of voting rights in the Company is 63,877,906. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Contacts:

 
 CVS Group plc                    Tel: 01379 644 
  Simon Innes, Chief Executive               288 
  Nick Perrin, Finance Director 
 N+1 Singer (Nominated Adviser     Tel: 020 7496 
  & Broker)                                 3000 
  Aubrey Powell 
  Liz Yong 
  James Hopton

This information is provided by RNS

The company news service from the London Stock Exchange

END

IOEGGURPWUPMGMC

(END) Dow Jones Newswires

March 14, 2017 13:29 ET (17:29 GMT)

Cvs (LSE:CVSG)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Cvs Charts.
Cvs (LSE:CVSG)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Cvs Charts.